All Stories

  1. Comparative analysis of AKT and the related biomarkers in uterine leiomyomas with MED12, HMGA2 , and FH mutations
  2. Paracrine Pathways in Uterine Leiomyoma Stem Cells Involve Insulinlike Growth Factor 2 and Insulin Receptor A
  3. Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study
  4. Molecular analyses of 6 different types of uterine smooth muscle tumors: Emphasis in atypical leiomyoma
  5. Down-Regulation of miR-29b Is Essential for Pathogenesis of Uterine Leiomyoma